Accueil » Publications 2017

Publications 2017

Thème: Autoimmunité, Transplantation, Inflammation ; ATI

1 Abbara S, Georgin-Lavialle S, Katia SS, Bachmeyer C, Senet P, Buob D, Audia S, Delcey V, Fellahi S, Bastard JP, Awad F, Legendre M, Amselem S, Grateau G. Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients. Joint Bone Spine. 2017 Mar;84(2):159-162. doi: 10.1016/j.jbspin.2016.02.021. PMID: 27238193. IF: 2.946. RHEUMATOLOGY, Q2.

2 Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. PMID: 28428120. IF: 8.961. IMMUNOLOGY, Q1.

3 Audia S, Rossato M, Trad M, Samson M, Santegoets K, Gautheron A, Bekker C, Facy O, Cheynel N, Ortega-Deballon P, Boulin M, Berthier S, Leguy-Seguin V, Martin L, Ciudad M, Janikashvili N, Saas P, Radstake T, Bonnotte B. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia. J Autoimmun. 2017 Feb;77:89-95. doi: 10.1016/j.jaut.2016.11.002. PMID: 27863820. IF: 7.641. IMMUNOLOGY, Q1.

4 Audia S, Santegoets K, Laarhoven AG, Vidarsson G, Facy O, Ortega-Deballon P, Samson M, Janikashvili N, Saas P, Bonnotte B, Radstake T. Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia. Clin Exp Immunol. 2017 May;188(2):275-282. doi: 10.1111/cei.12935. PMID: 28142207. IF: 3.410. IMMUNOLOGY, Q2.

5 Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. PMID: 28007457. IF: 33.900. ONCOLOGY, Q1.

6 Bamoulid J, Courivaud C, Coaquette A, Crépin T, Carron C, Gaiffe E, Roubiou C, Rebibou JM, Ducloux D. Late Persistent Positive EBV Viral Load and Risk of Solid Cancer in Kidney Transplant Patients. Transplantation. 2017 Jun;101(6):1473-1478. PMID: 27367471. IF: 3.678. TRANSPLANTATION, Q2. IMMUNOLOGY, Q2.

7 Bamoulid J, Crépin T, Courivaud C, Rebibou JM, Saas P, Ducloux D. Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword. Transplant Rev (Orlando). 2017 Jul;31(3):180-187. doi: 10.1016/j.trre.2017.02.004. PMID: 28456447. IF: 3.113. TRANSPLANTATION, Q2. IMMUNOLOGY, Q2.

8 Bamoulid J, Crepin T, Gaiffe E, Laheurte C, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Rebibou JM, Saas P, Courivaud C, Ducloux D. Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins. Transpl Immunol. 2017 Sep 20. pii: S0966-3274(17)30113-2. doi: 10.1016/j.trim.2017.09.002. [Epub ahead of print]. PMID: 28941751. IF: 1.780. IMMUNOLOGY, Q4. TRANSPLANTATION, Q3.

9 Bamoulid J, Roodenburg A, Staeck O, Wu K, Rudolph B, Brakemeier S, Halleck F, Lehner L, Schönemann C, Lachmann N, Budde K. Clinical Outcome of Patients with De Novo C1q-Binding Donor-Specific HLA Antibodies after Renal Transplantation. Transplantation. 2017 Sep;101(9):2165-2174. PMID: 27653301. IF: 3.690. TRANSPLANTATION, Q1.

10 Bamoulid J, Staeck O, Crépin T, Halleck F, Saas P, Brakemeier S, Ducloux D, Budde K. Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects. Nephrol Dial Transplant. 2017 Oct 1;32(10):1601-1608. PMID: 27798202. IF: 4.085. TRANSPLANTATION, NEPHROLOGY & UROLOGY, Q1.

11 Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D. Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study. Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923. PMID: 28120425. IF: 3.079. TRANSPLANTATION, Q2.

12 Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O. [Routine screening of splenic or portal vein thrombosis after splenectomy]. Rev Med Interne. 2017 Jan;38(1):3-7. doi: 10.1016/j.revmed.2016.08.003. PMID: 27639911. IF: 1.126. MEDICINE, GENERAL & INTERNAL, Q3.

13 Ceroi A, Masson D, Garnache-Ottou F, Saas P. [Liver X receptors as targets in inflammatory or leukemic plasmacytoid dendritic cells]. Med Sci (Paris). 2017 Mar;33(3):345-348. doi: 10.1051/medsci/20173303024. PMID: 28367824. IF: 0.417. MEDICINE, RESEARCH & EXPERIMENTAL, Q4.

14 Chouk M, Vidon C, Deveza E, Verhoeven F, Pelletier F, Prati C, Wendling D. « Puffy hand syndrome ». Joint Bone Spine. 2017 Jan;84(1):83-85. doi: 10.1016/j.jbspin.2016.05.001. PMID: 27269656. IF: 3.329. RHEUMATOLOGY, Q2.
15 Coutier F, Meaux Ruault N, Crepin T, Bouiller K, Gil H, Humbert S, Bedgedjian I, Magy-Bertrand N. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review. Ann Hematol. 2017 Sep 27. doi: 10.1007/s00277-017-3138-z. [Epub ahead of print]. PMID: 28956126. IF: 3.083. HEMATOLOGY, Q2.

16 Daguindau E, Gautier T, Chagué C, Pais de Barros JP, Deckert V, Lagrost L, Saas P. Is it time to reconsider the lipopolysaccharide paradigm in acute graft-versus-host disease? Front Immunol. 2017 Aug 9;8:952. IF: 6.429. IMMUNOLOGY, Q1.

17 de Boysson H, Liozon E, Larivière D, Samson M, Parienti JJ, Boutemy J, Maigné G, Martin Silva N, Ly K, Touzé E, Bonnotte B, Aouba A, Sacré K, Bienvenu B. Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study. J Rheumatol. 2017 Mar;44(3):297-303. pii: jrheum.161033. doi: 10.3899/jrheum.161033. PMID: 28089985. IF: 3.150. RHEUMATOLOGY, Q2.

18 Degano B, Soumagne T, Delaye T, Berger P, Perez T, Guillien A, Pellegrin JL, Launay D, Magy-Bertrand N, Agard C, Tiev KP, Hua-Huy T, Tardiff C, Diaz V, Chambellan A, Dinh-Xuan AT. Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis. Eur Respir J. 2017 Oct 19;50(4). pii: 1701008. doi: 10.1183/13993003.01008-2017. PMID: 29051271. IF: 10.509. RESPIRATOY SYSTEM, Q1.

19 Devilliers H, Vernier N, Muller G, Turcu A, Samson M, Bielefeld P, Besancenot JF. [Quality of life measures in SLE: An update]. Rev Med Interne. 2017 Apr 27. pii: S0248-8663(17)30097-8. doi: 10.1016/j.revmed.2017.03.004. [Epub ahead of print]. PMID: 28457682. IF: 1.126. MEDICINE, GENERAL & INTERNAL, Q3.

20 Ducloux D, Bamoulid J, Crepin T, Rebibou JM, Courivaud C, Saas P. Post-transplant immune activation: innocent bystander or insidious culprit of post-transplant accelerated atherosclerosis. Cell Transplant. 2016 Oct 27. doi: 10.3727/096368916X693545. [Epub ahead of print]. PMID: 27938472. IF: 3.427. CELL & TISSUE ENGINEERING, Q3. MEDICINE, RESEARCH & EXPERIMENTAL, Q2. TRANSPLANTATION, Q2.

21 Duquesnoy A, Danic B, Santos A, Martinaud C, Woimant G, Laperche S, Tiberghien P, Jauffret-Roustide M, Pillonel J; for the Steering Committee. Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France. Transfusion. 2017 Sep;57(9):2240-2247. doi: 10.1111/trf.14187. PMID: 2867131. IF: 3.386. HEMATOLOGY, Q2.

22 Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients. PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. PMID: 28915275. IF: 2.806. MULTIDISCIPLINAY SCIENCES, Q1.

23 Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, Saadoun D, Audia S, Rigolet A, Terrier B, Perlat A, Guillaud C, Renou F, Bernit E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N. Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series. Medicine (Baltimore). 2017 Mar;96(10):e6205. doi: 10.1097/MD.0000000000006205. PMID: 28272212. IF: 1.803. MEDICINE, GENERAL & INTERNAL, Q2.

24 Floccard B, Javaud N, Deroux A, Boccon-Gibod I, Fain O, Amarger S, Blanchard-Delaunay C, Jeandel PY, Marmion N, Ollivier Y, Pralong P, Gayet S, Du-Thanh A, Pelletier F, Sailler L, Robinson P, Launay D, Bouillet L; French Reference Centre for Angioedema (CREAK). Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement. Eur J Emerg Med. 2017 Oct;24(5):318-325. doi: 10.1097/MEJ.0000000000000446. PMID: 28059860. IF: 2.025. EMERGENCY MEDICINE, Q2.
25 Gallian P, Cabié A, Richard P, Paturel L, Charrel RN, Pastorino B, Leparc-Goffart I, Tiberghien P, de Lamballerie X. Zika virus in asymptomatic blood donors, Martinique: 2016. Blood. 2017 Jan 12;129(2):263-266. doi: 10.1182/blood-2016-09-737981. PMID: 27827826. IF: 13.164. HEMATOLOGY, Q1.
26 Gallian P, Couchouron A, Dupont I, Fabra C, Piquet Y, Djoudi R, Assal A, Tiberghien P. Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors. Transfusion. 2017 Jan;57(1):223-224. doi: 10.1111/trf.13889. PMID: 28097700. IF: 3.386. HEMATOLOGY, Q2.

27 Gallian P, Leparc-Goffart I, Richard P, Maire F, Flusin O, Djoudi R, Chiaroni J, Charrel R, Tiberghien P, de Lamballerie X. Epidemiology of Chikungunya Virus Outbreaks in Guadeloupe and Martinique, 2014: An Observational Study in Volunteer Blood Donors. PLoS Negl Trop Dis. 2017 Jan 12;11(1):e0005254. doi: 10.1371/journal.pntd.0005254. PMID: 28081120. IF: 3.834. PARASITOLOGY, Q1.

28 Gauthier AS, Billon-Grand R, Rivet A, Chatain M, Saleh M, Delbosc B. [Left inferior homonymous quadrantanopia secondary to dilation of the Virchow-Robin spaces: Case report]. J Fr Ophtalmol. 2017 Jan;40(1):82-83. doi: 10.1016/j.jfo.2016.07.022. PMID: 28062168. IF: 0.567. OPHTHALMOLOGY, Q4.

29 Gauthier AS, Castelbou M, Garnier MB, Pizzuto J, Roux S, Gain P, Pouthier F, Delbosc B. Corneal transplantation: study of the data of a regional eye bank for the year 2013 and analysis of the evolution of the adverse events reported in France since 2010. Cell Tissue Bank. 2017 Mar;18(1):83-89. doi: 10.1007/s10561-016-9593-2. PMID: 28116630. IF: 1.331. CELL BIOLOGY, Q4 – ENGINEERING, BIOMEDICAL, Q3.

30 Gauthier AS, Friot M, Puyraveau M, Garcin T, Saleh M, Gain P, Delbosc B. Visual outcomes of the second eye in keratoconic patients who have a corneal graft in the first eye: analysis at 12 years. Eur J Ophthalmol. 2017 Jun 10:0. doi: 10.5301/ejo.5000996. [Epub ahead of print]. PMID: 28604983. IF: 1.192. OPHTHALMOLOGY, Q4.

31 Gauthier AS, Garcin T, Thuret G, He Z, Jullienne R, Trone MC, Nefzaoui C, Acquart S, Forest F, Péoc’h M, Delbosc B, Gain P. Very early endothelial cell loss after penetrating keratoplasty with organ-cultured corneas. Br J Ophthalmol. 2017 Aug;101(8):1113-1118. doi: 10.1136/bjophthalmol-2016-309615. PMID: 27965261. IF: 3.806, OPHTALMOLGY, Q1.

32 Gauthier J, Castagna L, Garnier F, Guillaume T, Socié G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Béguin Y, Delage J, Turlure P, Marçais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Régny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplant. 2017 May;52(5):689-696. doi: 10.1038/bmt.2016.349. PMID: 28067872. IF: 3.874. HEMATOLOGY, ONCOLOGY, IMMUNOLOGY, TRANSPLANTATION: Q2.

33 Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Loundou A, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Bonotte B, Farnarier C, Harlé JR, Costedoat-Chalumeau N, Vély F, Schleinitz N. T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease. Front Immunol. 2017 Mar 13;8:235. doi: 10.3389/fimmu.2017.00235. eCollection 2017. PMID: 28348556. IF: 6.429. IMMUNOLOGY, Q1.

34 Grèze V, Brugnon F, Chambon F, Halle P, Canis M, Amiot C, Grémeau AS, Pereira B, Yáñez Peralta Y, Tchirkov A, Kanold J. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration. Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26287. PMID: 27734578. IF: 2.634. PEDIATRICS, Q1. HEMATOLOGY & ONCOLOGY, Q3.

35 Hunault-Berger M, Maillard N, Himberlin C, Recher C, Schmidt-Tanguy A, Choufi B, Bonmati C, Carré M, Couturier MA, Daguindau E, Marolleau JP, Orsini-Piocelle F, Delaunay J, Tavernier E, Lissandre S, Ojeda-Uribe M, Sanhes L, Sutton L, Banos A, Fornecker LM, Bernard M, Bouscary D, Saad A, Puyade M, Rouillé V, Luquet I, Béné MC, Hamel JF, Dreyfus F, Ifrah N, Pigneux A. Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial. Blood Cancer J. 2017 Jun 2;7(6):e568. doi: 10.1038/bcj.2017.50. PMID: 28574488. IF: 6.126. ONCOLOGY, Q1.

36 Johnpulle RA, Paczesny S, Jung DK, Daguindau E, Jagasia MH, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Byrne MT, Engelhardt BG. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling. Biol Blood Marrow Transplant. 2017 Mar;23(3):529-532. doi: 10.1016/j.bbmt.2016.12.627. PMID: 28013014. IF: 4.704. HEMATOLOGY, Q1. IMMUNOLOGY, Q1. TRANSPLANTATION, Q1.

37 Kanakry CG, Bakoyannis G, Perkins SM, McCurdy SR, Vulic A, Warren EH, Daguindau E, Olmsted T, Mumaw C, Towlerton AM, Cooke KR, O’Donnell PV, Symons HJ, Paczesny S, Luznik L. Plasma-derived proteomic biomarkers in HLA-haploidentical or HLA-matched bone marrow transplantation using post-transplantation cyclophosphamide. Haematologica. 2017 May;102(5):932-940. doi: 10.3324/haematol.2016.152322. PMID: 28126963. IF: 7.702. HEMATOLOGY, Q1.

38 Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun;16(6):650-657. pii: S1568-9972(17)30108-8. doi: 10.1016/j.autrev.2017.04.011. PMID: 28434948. IF: 8.961. IMMUNOLOGY, Q1.

39 Kormann R, François H, Moles T, Dantal J, Kamar N, Moreau K, Bachelet T, Heng AE, Garstka A, Colosio C, Ducloux D, Sayegh J, Savenkoff B, Viglietti D, Sberro R, Rondeau E, Peltier J. Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature. PLoS One. 2017 Jun 21;12(6):e0179406. doi: 10.1371/journal.pone.0179406. PMID: 28636627. IF: 2.806. MULTIDISCIPLINARY SCIENCES, Q1.

40 Kraeber-Bodere F, Pallardy A, Maisonneuve H, Campion L, Moreau A, Soubeyran I, Le Gouill S, Tournilhac O, Daguindau E, Jardel H, Morineau N, Bouabdallah K, Gyan E, Moles MP, Gressin R, Berthou C, Sadot S, Moreau P, Deau B, Bodet-Milin C, Cazeau AL, Garin E, Salaun PY, Vuillez JP, Gouilleux-Gruart V, Barbet J, Wegener WA, Goldenberg DM, Lamy T, Soubeyran P. Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. Lancet Haematol. 2017 Jan;4(1):e35-e45. doi: 10.1016/S2352-3026(16)30168-5. PMID: 27964867. IF: 7.123. HEMATOLOGY, Q1.

41 Laperche S, Tiberghien P, Roche-Longin C, Pillonel J. Fifteen years of Nucleic Acid Testing in France: Results and lessons. Transfus Clin Biol. 2017 Sep;24(3):182-188. pii: S1246-7820(17)30101-5. doi: 10.1016/j.tracli.2017.06.020. PMID: 28709845. IF: 0.741. HEMATOLOGY, Q4. IMMUNOLOGY, Q4.

42 Le Bourgeois A, Labopin M, Blaise D, Ceballos P, Vigouroux S, Peffault de Latour R, Marçais A, Bulabois CE, Bay JO, Chantepie S, Deconinck E, Daguindau E, Contentin N, Yakoub-Agha I, Cornillon J, Mercier M, Turlure P, Charbonnier A, Rorhlich PS, N’Guyen S, Maillard N, Marchand T, Mohty M, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Ann Oncol. 2017 Sep 1;28(9):2191-2198. doi: 10.1093/annonc/mdx274. PMID: 28911060. IF: 11.855. ONCOLOGY, Q1.

43 Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S, Roblin X, Sibilia J, Blum M, Danese S, Bonovas S, Peyrin-Biroulet L. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. J Autoimmun. 2017 Jun;80:10-27. doi: 10.1016/j.jaut.2017.03.011. PMID: 28381345. IF: 7.641. IMMUNOLOGY, Q1.

44 Michel M, Terriou L, Roudot-Thoraval F, Hamidou M, Ebbo M, Le Guenno G, Galicier L, Audia S, Royer B, Sophie Morin A, Michot JM, Jaccard A, Frenzel L, Khellaf M, Godeau B. A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study). Am J Hematol. 2017 Jan;92(1):23-27. doi: 10.1002/ajh.24570. PMID: 27696475. IF: 5.275. HEMATOLOGY, Q1.

45 Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry-Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D. Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary. Vox Sang. 2017 Oct;112(7):680-683. doi: 10.1111/vox.12522. Epub 2017 Sep 14. PMID: 28905391. IF: 2.192. HEMATOLOGY, Q3.

46 Obeid S, Ceroi A, Mourey G, Saas P, Elie-Caille C, Boireau W. Development of a NanoBioAnalytical platform for « on-chip » qualification and quantification of platelet-derived microparticles. Biosens Bioelectron. 2017 Jul 15;93:250-259. doi: 10.1016/j.bios.2016.08.100. PMID: 27597127. IF: 7.780. NANOSCIENCE & NANOTECHNOLOGY, Q1. BIOTECHNOLOGY AND APPLIED MICROBIOLOGY, Q1.

47 Rivet A, Gauthier AS, Chatain M, Billon-Grand R, Thines L, Delbosc B. A Giant Tumefactive Virchow-Robin Space: A Rare Cause of a Homonymous Quadrantanopia. J Neuroophthalmol. 2017 Mar;37(1):75-76. doi: 10.1097/WNO.0000000000000478. PMID: 28059864. No IF.

48 Saas P, Bonnefoy F, Toussirot E, Perruche S. Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis. Front Immunol. 2017 Oct 9;8:1191. doi: 10.3389/fimmu.2017.01191. PMID: 29062314. IF: 6.429. IMMUNOLOGY, Q1.

49 Saas P, Varin A, Perruche S, Ceroi A. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions. F1000Res. 2017 Apr 10;6:456. [revised 2017 Jun 1]. doi: 10.12688/f1000research.11332.1. PMID: 28580131. No IF.

50 Saleh M, Flores M, Gauthier AS, Elphege E, Delbosc B. Quantitative analysis of photoreceptor layer reflectivity on en-face optical coherence tomography as an estimator of cone density. Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2119-2126. doi: 10.1007/s00417-017-3761-3. Epub 2017 Aug 8. PMID: 28791546. IF:2.349. OPHTALMOLOGY, Q2.

51 Samson M, Bonnotte B. [From pathogenesis of giant cell arteritis to new therapeutic targets]. Rev Med Interne. 2017 Oct;38(10):670-678. doi: 10.1016/j.revmed.2017.06.016. PMID: 28800947. IF: 1.126. MEDICINE, GENERAL & INTERNAL, Q3.

52 Samson M, Corbera-Bellalta M, Audia S, Planas-Rigol E, Martin L, Cid MC, Bonnotte B. Recent advances in our understanding of giant cell arteritis pathogenesis. Autoimmun Rev. 2017 Aug;16(8):833-844. doi: 10.1016/j.autrev.2017.05.014. PMID: 28564617. IF: 8.961. IMMUNOLOGY, Q1.

53 Samson M, Ghesquière T, Berthier S, Bonnotte B. Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis. Ann Rheum Dis. 2017 May 13. pii: annrheumdis-2017-211622. doi: 10.1136/annrheumdis-2017-211622. [Epub ahead of print] PMID: 28501800. IF: 12.811. RHEUMATOLOGY, Q1.

54 Samson M, Puéchal X, Mouthon L, Devilliers H, Cohen P, Bienvenu B, Ly KH, Bruet A, Gilson B, Ruivard M, Pertuiset E, Hamidou M, Pagnoux C, Terrier B, Guillevin L; French Vasculitis Study Group (FVSG). Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):176-184. PMID: 28422001. IF: 2.634. Rheumatology, Q3.

55 Samson M, Terrier B, Mangin O, Mouthon L; Collège national des enseignants de médecine interne (CEMI). [Inventory of training of internal medicine in France: Results of a national survey]. Rev Med Interne. 2017 May;38(5):300-306. doi: 10.1016/j.revmed.2016.10.385. PMID: 27889326. IF: 1.126. MEDICINE, GENERAL & INTERNAL, Q3.

56 Sut C, Hamzeh-Cognasse H, Laradi S, Bost V, Aubrège C, Acquart S, Vignal M, Boutahar N, Arthaud CA, Ange Eyraud M, Pozzetto B, Tiberghien P, Garraud O, Cognasse F. Properties of donated red blood cell components from patients with hereditary hemochromatosis. Transfusion. 2017 Jan;57(1):166-177.doi: 10.1111/trf.13890. PMID: 27807848. IF: 3.386. HEMATOLOGY, Q2.

57 Tiberghien P, Pillonel J, Toujas F, Vallet B. Changes in France’s Deferral of Blood Donation by Men Who Have Sex with Men. N Engl J Med. 2017 Apr 13;376(15):1485-1486. doi: 10.1056/NEJMc1700740. PMID: 28402774. IF: 72.406. Medicine, GENERAL & INTERNAL, Q1.

58 Toussirot E, Michel F, Béreau M, Dehecq B, Gaugler B, Wendling D, Grandclément E, Saas P, Dumoulin G. Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritis. Clin Rheumatol. 2017 Nov;36(11):2531-2539. doi: 10.1007/s10067-017-3789-0. PMID: 28831581. IF: 2.365. RHEUMATOLOGY, Q3.

59 Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A. Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J. 2017 Aug;10(4):461-469. doi: 10.1093/ckj/sfw101. PMID: 28852482. No IF.

60 Watelet B, Samson M, de Boysson H, Bienvenu B. Treatment of giant-cell arteritis, a literature review. Mod Rheumatol. 2017 Jan 13:1-8. doi: 10.1080/14397595.2016.1266070. PMID: 27919193. IF: 1.818. RHEUMATOLOGY, Q3.

61 Yafour N, Beckerich F, Bulabois CE, Chevallier P, Daguindau E, Dumesnil C, Guillaume T, Huynh A, Masouridi Levrat S, Menard AL, Pautas C, Poiré X, Ravinet A, Michallet M, Bazarbachi A. How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome. Curr Res Transl Med. 2017 Apr-Jun;65(2):65-69. pii: S2452-3186(17)30017-X. doi: 10.1016/j.retram.2017.06.001. PMID: 28687223. No IF.

62 Zver T, Mouloungui E, Berdin A, Roux C, Amiot C. Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry. J Ovarian Res. 2017 Jun 23;10(1):38. doi: 10.1186/s13048-017-0337-0. PMID: 28645304. IF: 2.461. REPRODUCTIVE BIOLOGY, Q3.

Thème: Thérapeutique ImmunoMoléculaire des Cancers ; TIM-C

1 Asgarov K, Balland J, Tirole C, Bouard A, Mougey V, Ramos D, Barroso A, Zangiacomi V, Jary M, Kim S, Gonzalez-Pajuelo M, Royer B, de Haard H, Clark A, Wijdenes J, Borg C. A new anti-mesothelin antibody targets selectively the membrane-associated form. MAbs. 2017 Apr;9(3):567-577. doi: 10.1080/19420862.2017.1288770. PMID: 28353419. IF: 4.881. MEDICINE RESEARCH & EXPERIMENTAL, Q1.

2 Auclin E, Zaanan A, Vernerey D, Douard R, Gallois C, Laurent-Puig P, Bonnetain F, Taieb J. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy. Ann Oncol. 2017 May 1;28(5):958-968. doi: 10.1093/annonc/mdx030. PMID: 28453690. IF: 11.855. ONCOLOGY, Q1.

3 Bachet JB, Hammel P, Desramé J, Meurisse A, Chibaudel B, André T, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Meyer VG, Taieb J, Volet J, Monier A, Bonnetain F, Louvet C. Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2017 May;2(5):337-346. doi: 10.1016/S2468-1253(17)30046-8. PMID: 28397697. No IF.

4 Bell R, Brown J, Parmar M, Toi M, Suter T, Steger GG, Pivot X, Mackey J, Jackisch C, Dent R, Hall P, Xu N, Morales L, Provencher L, Hegg R, Vanlemmens L, Kirsch A, Schneeweiss A, Masuda N, Overkamp F, Cameron D. Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. Ann Oncol. 2017 Apr 1;28(4):754-760. doi: 10.1093/annonc/mdw665. PMID: 27993816. IF: 11.855. ONCOLOGY, Q1.

5 Bellanger AP, Cervoni JP, Faucher JF, Weil-Verhoeven D, Ginet M, Deconinck E, Grenouillet F. Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant. Mycopathologia. 2017 Aug;182(7-8):761-765. doi: 10.1007/s11046-017-0131-y. PMID: 28365835. IF: 1.710. MYCOLOGY, Q3.

6 Bellanger AP, Lignon T, Godet Y, Rognon B, Reboux G, Gbaguidi-Haore H, Borg C, Millon L. Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune response. J Immunol Methods. 2017 Jan;440:67-73. doi: 10.1016/j.jim.2016.11.009. PMID: 27876506. IF: 2.100. IMMUNOLOGY, Q4.

7 Bellanger AP, Mougey V, Pallandre JR, Gbaguidi-Haore H, Godet Y, Millon L. Echinococcus multilocularis vesicular fluid inhibits activation and proliferation of natural killer cells. Folia Parasitol (Praha). 2017 Aug 25;64. pii: 2017.029. doi: 10.14411/fp.2017.029. PMID: 28906255. IF: 1.082. PARASITOLOGY, Q4.

8 Bennouna J, Falchero L, Schott R, Bonnetain F, Coudert M, Ben Hadj Yahia B, Chouaid C. Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE). Oncology. 2017 Oct 25. doi: 10.1159/000480702. [Epub ahead of print]. PMID: 29065416. IF: 3.975. ONCOLOGY, Q3.

9 Boisdron-Celle M, Capitain O, Faroux R, Borg C, Metges JP, Galais MP, Kaassis M, Bennouna J, Bouhier-Leporrier K, Francois E, Baumgaertner I, Guerin-Meyer V, Cojocarasu O, Roemer-Becuwe C, Stampfli C, Rosenfeld L, Lecompte T, Berger V, Morel A, Gamelin E. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach. Semin Oncol. 2017 Feb;44(1):13-23. doi: 10.1053/j.seminoncol.2017.02.008. PMID: 28395758. IF: 6.212. ONCOLOGY, Q1.

10 Boisdron-Celle M, Capitain O, Faroux R, Borg C, Philippe Metges J, Galais MP, Kaassis M, Bennouna J, Bouhier-Leporrier K, Francois E, Baumgaertner I, Guerin-Meyer V, Cojocarasu O, Roemer-Becuwe C, Stampfli C, Rosenfeld L, Lecompte T, Berger V, Morel A, Gamelin E. In reply. Semin Oncol. 2017 Apr;44(2):161. doi: 10.1053/j.seminoncol.2017.08.002. PMID: 28923216. IF: 6.212. ONCOLOGY, Q1.

11 Bonnetain F, Borg C, Adams RR, Ajani JA, Benson A, Bleiberg H, Chibaudel B, Diaz-Rubio E, Douillard JY, Fuchs CS, Giantonio BJ, Goldberg R, Heinemann V, Koopman M, Labianca R, Larsen AK, Maughan T, Mitchell E, Peeters M, Punt CJA, Schmoll HJ, Tournigand C, de Gramont A. How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials. Ann Oncol. 2017 Sep 1;28(9):2077-2085. doi: 10.1093/annonc/mdx191. PMID: 28430862. IF: 11.855. ONCOLOGY, Q1.

12 Borg C. [Immuno-oncology and precision medicine: The clinician point of view]. Ann Pathol. 2017 Feb;37(1):5-6. doi: 10.1016/j.annpat.2016.12.003. PMID: 28159403. IF: 0.615. PATHOLOGY, Q4.

13 Bourmaud A, Anota A, Moncharmont C, Tinquaut F, Oriol M, Trillet-Lenoir V, Bajard A, Parnalland S, Rotonda C, Bonnetain F, Pérol D, Chauvin F. Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study. Br J Cancer. 2017 Mar 28;116(7):849-858. doi: 10.1038/bjc.2017.31. PMID: 28196066. IF: 6.176. ONCOLOGY, Q1.

14 Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A. Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT. Am J Hematol. 2017 Apr;92(4):344-350. doi: 10.1002/ajh.24640. PMID: 28052366. IF: 5.275. HEMATOLOGY, Q1.

15 Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT. Am J Hematol. 2017 Jul;92(7):653-659. doi: 10.1002/ajh.24737. PMID: 28370339. IF: 5.275. HEMATOLOGY, Q1.

16 Caoduro C, Hervouet E, Girard-Thernier C, Gharbi T, Boulahdour H, Delage-Mourroux R, Pudlo M. Carbon nanotubes as gene carriers: Focus on internalization pathways related to functionalization and properties. Acta Biomater. 2017 Feb;49:36-44. doi: 10.1016/j.actbio.2016.11.013. PMID: 27826000. IF: 6.319. ENGINEERING, BIOMEDICAL, Q1.

17 Chau I, Peck-Radosavljevic M, Borg C, Malfertheiner P, Seitz JF, Park JO, Ryoo BY, Yen CJ, Kudo M, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Okusaka T, Bowman L, Cui ZL, Girvan AC, Abada PB, Yang L, Zhu AX. Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study. Eur J Cancer. 2017 Aug;81:17-25. doi: 10.1016/j.ejca.2017.05.001. PMID: 28591675. IF: 6.029. ONCOLOGY, Q1.

18 Curtit E, Mansi L, Maisonnette-Escot Y, Sautière JL, Pivot X. Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay. Eur J Surg Oncol. 2017 May;43(5):921-930. doi: 10.1016/j.ejso.2016.11.016. PMID: 28087099. IF: No IF after 2005.

19 Curtit E, Pivot X, Henriques J, Paget-Bailly S, Fumoleau P, Rios M, Bonnefoi H, Bachelot T, Soulié P, Jouannaud C, Bourgeois H, Petit T, Tennevet I, Assouline D, Mathieu MC, Jacquin JP, Lavau-Denes S, Darut-Jouve A, Ferrero JM, Tarpin C, Lévy C, Delecroix V, Trillet-Lenoir V, Cojocarasu O, Meunier J, Pierga JY, Kerbrat P, Faure-Mercier C, Blanché H, Sahbatou M, Boland A, Bacq D, Besse C, Thomas G, Deleuze JF, Pauporté I, Romieu G, Cox DG. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes. Breast Cancer Res. 2017 Aug 22;19(1):98. doi: 10.1186/s13058-017-0888-4. PMID: 28830573. IF: 3.626. ONCOLOGY, Q2.

20 Eisinger F, Pivot X, Greillier L, Couraud S, Cortot AB, Touboul C, Lhomel C, Blay JY, Morère JF, Viguier J. [Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys]. Bull Cancer. 2017 Mar;104(3):258-266. doi: 10.1016/j.bulcan.2016.12.002. PMID: 28108012. No IF.
21 Es-Saad I, Paget-Bailly S, Fritzsch J, Mouillet G, Bonnetain F. [Assessment of the quality of life with regard to health following a cancer diagnosis]. Rev Infirm. 2017 Jan;66(227):36-37. doi: 10.1016/j.revinf.2016.11.013. PMID: 28048994. No IF.

22 Etienne-Grimaldi MC, Boyer JC, Beroud C, Mbatchi L, van Kuilenburg A, Bobin-Dubigeon C, Thomas F, Chatelut E, Merlin JL, Pinguet F, Ferrand C, Meijer J, Evrard A, Llorca L, Romieu G, Follana P, Bachelot T, Chaigneau L, Pivot X, Dieras V, Largillier R, Mousseau M, Goncalves A, Roché H, Bonneterre J, Servent V, Dohollou N, Château Y, Chamorey E, Desvignes JP, Salgado D, Ferrero JM, Milano G. New advances in DPYD genotype and risk of severe toxicity under capecitabine. PLoS One. 2017 May 8;12(5):e0175998. doi: 10.1371/journal.pone.0175998. eCollection 2017. PMID: 28481884. IF: 2.806. MULTIDISCIPLINARY SCIENCES, Q1.

23 Fiteni F, Bonnetain F. Reply to Sorscher S. Breast. 2017 Jun;33:203. doi: 10.1016/j.breast.2016.12.005. PMID: 28024714. IF: 2.801. ONCOLOGY, Q3.
24 Fiteni F, Paillard MJ, Westeel V, Bonnetain F. Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials. Expert Rev Anticancer Ther. 2017 Feb;17(2):167-173. doi: 10.1080/14737140.2016.1271718. PMID: 27937067. IF: 2.212. ONCOLOGY, Q3.

25 Fiteni F, Westeel V, Bonnetain F. Surrogate endpoints for overall survival in lung cancer trials: a review. Expert Rev Anticancer Ther. 2017 May;17(5):447-454. doi: 10.1080/14737140.2017.1316196. PMID: 28399678. IF: 2.212. ONCOLOGY, Q3.

26 Fizazi K, Ulys A, Sengeløv L, Moe M, Ladoire S, Thiery-Vuillemin A, Flechon A, Guida A, Bellmunt J, Climent MA, Chowdhury S, Dumez H, Matouskova M, Penel N, Liutkauskiene S, Stachurski L, Sternberg CN, Baton F, Germann N, Daugaard G. A randomized, double blind, placebo controlled phase 2 study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy. Ann Oncol. 2017 Oct 20. doi: 10.1093/annonc/mdx487. [Epub ahead of print]. PMID: 29059273. IF: 11.855. ONCOLOGY, Q1.

27 Gamonet C, Mourey G, Aupet S, Biichle S, Petitjean R, Vidal C, Pugin A, Naegelen C, Tiberghien P, Morel P, Angelot-Delettre F, Seilles E, Saas P, Bardiaux L, Garnache-Ottou F. How to quantify microparticles in RBCs? A validated flow cytometry method allows the detection of an increase in microparticles during storage. Transfusion. 2017 Mar;57(3):504-516. [Erratum in: Transfusion. 2017 Jun;57(6):1584.] doi: 10.1111/trf.13989. PMID: 28164307. IF: 3.386. HEMATOLOGY, Q2.

28 Gérard C, Fagnoni P, Vienot A, Borg C, Limat S, Daval F, Calais F, Vardanega J, Jary M, Nerich V. A systematic review of economic evaluation in pancreatic ductal adenocarcinoma. Eur J Cancer. 2017 Oct 9;86:207-216. doi: 10.1016/j.ejca.2017.08.035. PMID: 29024890. IF: 6.029. ONCOLOGY, Q1.

29 Geri G, Dumas F, Bonnetain F, Bougouin W, Champigneulle B, Arnaout M, Carli P, Marijon E, Varenne O, Mira JP, Empana JP, Cariou A. Predictors of long-term functional outcome and health-related quality of life after out-of-hospital cardiac arrest. Resuscitation. 2017 Apr;113:77-82. doi: 10.1016/j.resuscitation.2017.01.028. PMID: 28202421. IF: 5.230. CRITICAL CARE MEDICINE, EMERGENCY MEDICINE, Q1.

30 Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study’s primary analysis of 2573 patients. Eur J Cancer. 2017 Sep;82:237-246. pii: S0959-8049(17)30961-9. doi: 10.1016/j.ejca.2017.05.010. PMID: 28625777. IF: 6.029. ONCOLOGY, Q1.

31 Gligorov J, Curigliano G, Müller V, Knoop A, Jenkins V, Verma S, Osborne S, Lauer S, Machackova Z, Fallowfield L, Pivot X. Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial. Breast. 2017 Aug;34:89-95. doi: 10.1016/j.breast.2017.05.004. PMID: 28549309. IF: 2.801. ONCOLOGY, Q3.

32 Gravis G, Audenet F, Irani J, Timsit MO, Barthelemy P, Beuzeboc P, Fléchon A, Linassier C, Oudard S, Rebillard X, Richaud P, Rouprêt M, Thiery Vuillemin A, Vincendeau S, Albiges L, Rozet F. Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature. Cancer Treat Rev. 2017 Apr;55:211-217. doi: 10.1016/j.ctrv.2016.09.008. PMID: 27665366. IF: 8.589. ONCOLOGY, Q1.

33 Guenat D, Deroo O, Magnin S, Chaigneau L, Monnien F, Borg C, Mougin C, Emile JF, Prétet JL. Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors. Oncol Rep. 2017 Mar;37(3):1671-1681. doi: 10.3892/or.2017.5384. PMID: 28098915. IF: 2.662. ONCOLOGY, Q3.
34 Guenat D, Merla G, Deconinck E, Borg C, Rohrlich PS. DNA damage response defect in Williams-Beuren syndrome. Int J Mol Med. 2017 Mar;39(3):622-628. doi: 10.3892/ijmm.2017.2861. PMID: 28098859. IF: 2.341. MEDICINE, RESEARCH & EXPERIMENTAL, Q3.

35 Hammel P, Coriat R, Lledo G, de Bausset M, Selosse M, Obled S, Bonnetain F. Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey. Bull Cancer. 2017 Apr;104(4):321-331. doi: 10.1016/j.bulcan.2016.11.022. PMID: 28087054. No IF.
36 Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, Borg C, Dalle S, Beatrix O, Ayyoub M, Balme B, Tomasic G, Di Giacomo AM, Maio M, Schadendorf D, Melero I, Dréno B, Khammari A, Dummer R, Levesque M, Koguchi Y, Fong L, Lotem M, Baniyash M, Schmidt H, Svane IM, Kroemer G, Marabelle A, Michiels S, Cavalcanti A, Smyth MJ, Weber JS, Eggermont AM, Zitvogel L. Predictors of responses to immune checkpoint blockade in advanced melanoma. Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2. PMID: 28928380. IF: 12.124. MULTIDISCIPLINARY SCIENCES, Q1.

37 Jacquinot Q, Meneveau N, Chatot M, Bonnetain F, Degano B, Bouhaddi M, Dumoulin G, Vernerey D, Pivot X, Mougin F. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study. BMC Cancer. 2017 Jun 19;17(1):425. doi: 10.1186/s12885-017-3420-4. PMID: 28629338. IF: 3.288. ONCOLOGY, Q2.

38 Kim S, Bisch A, Montange D, Paillard MJ, Nguyen T, Jary M, Jacquin M, Winkfield B, Borg C, Royer B. A simple and fast LC-MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Aug 15;1060:240-246. doi: 10.1016/j.jchromb.2017.06.021. PMID: 28628839. IF: 2.603. BIOCHEMICAL RESEARCH METHOD, Q2. CHEMISTRY, ANALYTICAL, Q2.

39 Kim S, Jary M, André T, Vendrely V, Buecher B, François E, Bidard FC, Dumont S, Samalin E, Peiffert D, Pernot S, Baba-Hamed N, El Hajbi F, Bouché O, Desrame J, Parzy A, Zoubir M, Louvet C, Bachet JB, Nguyen T, Abdelghani MB, Smith D, De La Fouchardière C, Aparicio T, Bennouna J, Gornet JM, Jacquin M, Bonnetain F, Borg C. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study). BMC Cancer. 2017 Aug 25;17(1):574. doi: 10.1186/s12885-017-3566-0. PMID: 28841909. IF: 3.288. ONCOLOGY, Q2.

40 Kim S, Paget-Bailly S, Messager M, Nguyen T, Mathieu P, Lamfichekh N, Fein F, Fratté S, Cléau D, Lakkis Z, Jary M, Sakek N, Jacquin M, Foubert A, Bonnetain F, Mariette C, Fiteni F, Borg C. Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. Eur J Surg Oncol. 2017 Jan;43(1):218-225. doi: 10.1016/j.ejso.2016.06.395. PMID: 27425578. No IF after 2005.

41 Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, Gressin R, Cornillon J, Banos A, Le Du K, Benchalal M, Moles MP, Le Gouill S, Fleury J, Godmer P, Maisonneuve H, Deconinck E, Houot R, Laribi K, Marolleau JP, Tournilhac O, Branger B, Devillers A, Vuilliez JP, Fest T, Colombat P, Costes V, Szablewski V, Béné MC, Delwail V. R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL). Blood. 2017 Oct 23. pii: blood-2017-07-793984. doi: 10.1182/blood-2017-07-793984. [Epub ahead of print]. PMID: 29061568. . IF: 13.164. HEMATOLOGY, Q1.

42 Lereclus E, Tout M, Girault A, Baroukh N, Caulet M, Borg C, Bouché O, Ternant D, Paintaud G, Lecomte T, Raoul W. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen. BMC Cancer. 2017 Mar 27;17(1):220. doi: 10.1186/s12885-017-3210-z. PMID: 28347290. IF: 3.288. ONCOLOGY, Q2.

43 Meynard G, Mansi L, Lebahar P, Villanueva C, Klajer E, Calcagno F, Vivalta A, Chaix M, Collonge-Rame MA, Populaire C, Algros MP, Colpart P, Neidich J, Pivot X, Curtit E. First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. Oncol Rep. 2017 Mar;37(3):1573-1578. doi: 10.3892/or.2017.5422. PMID: 28184945. IF: 2.662. ONCOLOGY, Q3.

44 Moreau J, Pelletier F, Biichle S, Mourey G, Puyraveau M, Badet N, Caubet M, Laresche C, Garnache-Ottou F, Saas P, Seilles E, Aubin F. Increased levels of circulating platelet-derived microparticles is associated with metastatic cutaneous melanoma. Exp Dermatol. 2017 Oct;26(10):961-963. doi: 10.1111/exd.13339. PMID: 28266752. IF: 2.679. DERMATOLOGY, Q1.

45 Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouché O. Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP). Dig Liver Dis. 2017 Aug;49(8):831-840. doi: 10.1016/j.dld.2017.05.011. PMID: 28610905. IF: 3.061. GASTROENTEROLOGY AND HEPATOLOGY, Q2.

46 Nerich V, Fleck C, Chaigneau L, Isambert N, Borg C, Kalbacher E, Jary M, Simon P, Pivot X, Blay JY, Limat S. Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors. Clin Drug Investig. 2017 Jan;37(1):85-94. doi: 10.1007/s40261-016-0463-2. PMID: 27665470. IF: 1.853. PHARMACOLOGY & PHARMACY, Q3.

47 Nerich V, Saing S, Gamper EM, Holzner B, Pivot X, Viney R, Kemmler G. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses. Breast Cancer Res Treat. 2017 Aug;164(3):527-536. doi: 10.1007/s10549-017-4283-8. PMID: 28497177. IF: 3.626. ONCOLOGY, Q2.

48 Oudard S, Fizazi K, Sengeløv L, Daugaard G, Saad F, Hansen S, Hjälm-Eriksson M, Jassem J, Thiery-Vuillemin A, Caffo O, Castellano D, Mainwaring PN, Bernard J, Shen L, Chadjaa M, Sartor O. Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. J Clin Oncol. 2017 Oct 1;35(28):3189-3197. doi: 10.1200/JCO.2016.72.1068. PMID: 28753384. IF : 24.008. ONCOLOGY, Q1.
49 Pautier P, Kalbacher E, de la Motte Rouge T, Bonnetain F, Lesoin A. Cancer de l’ovaire : la rechute précoce. Bull Cancer. 2017 May;104 Suppl 1:S32-S38. doi: 10.1016/S0007-4551(17)30160-1. PMID: 28625313. No IF.

50 Perez EA, Barrios C, Eiermann W, Toi M, Im YH, Conte P, Martin M, Pienkowski T, Pivot X, Burris H 3rd, Petersen JA, Stanzel S, Strasak A, Patre M, Ellis P. Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study. J Clin Oncol. 2017 Jan 10;35(2):141-148. PMID: 28056202. IF : 24.008. ONCOLOGY, Q1.

51 Pernot S, Badoual C, Terme M, Castan F, Cazes A, Bouche O, Bennouna J, Francois E, Ghiringhelli F, De La Fouchardiere C, Samalin E, Bachet JB, Borg C, Ducreux M, Marcheteau E, Stanbury T, Gourgou S, Malka D, Taieb J. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects. Eur J Cancer. 2017 Jul;79:15-22. doi: 10.1016/j.ejca.2017.03.036. PMID: .28456090. IF: 6.029. ONCOLOGY, Q1.

52 Philippe L, Ceroi A, Bôle-Richard E, Jenvrin A, Biichle S, Perrin S, Limat S, Bonnefoy F, Deconinck E, Saas P, Garnache-Ottou F, Angelot-Delettre F. Bortezomib as a new therapeutic approach for Blastic Plasmacytoid Dendritic Cell Neoplasm. Haematologica. 2017 Aug 10. pii: haematol.2017.169326. doi: 10.3324/haematol.2017.169326. [Epub ahead of print]. PMID: 287980712017. IF: 7.702. HEMATOLOGY, Q1.

53 Pivot X. Classic cytotoxic drugs: a narrow path for regulatory approval. Lancet Oncol. 2017 Mar;18(3):279-281. doi: 10.1016/S1470-2045(17)30089-X. PMID: 28209299. IF: 33.900. ONCOLOGY, Q1.

54 Pivot X, Fumoleau P, Pierga JY, Delaloge S, Bonnefoi H, Bachelot T, Jouannaud C, Bourgeois H, Rios M, Soulié P, Jacquin JP, Lavau-Denes S, Kerbrat P, Cox D, Faure-Mercier C, Pauporte I, Gligorov J, Curtit E, Henriques J, Paget-Bailly S, Romieu G. Superimposable outcomes for sequential and concomitant administration of adjuvant trastuzumab in HER2-positive breast cancer: Results from the SIGNAL/PHARE prospective cohort. Eur J Cancer. 2017 Aug;81:151-160. doi: 10.1016/j.ejca.2017.05.020. PMID: 28624696. IF: 6.029. ONCOLOGY, Q1.

55 Pivot X, Romieu G, Fumoleau P, Rios M, Bonnefoi H, Bachelot T, Soulié P, Jouannaud C, Bourgeois H, Petit T, Tennevet I, Assouline D, Mathieu MC, Jacquin JP, Lavau-Denes S, Darut-Jouve A, Ferrero JM, Tarpin C, Lévy C, Delecroix V, Trillet-Lenoir V, Cojocarasu O, Meunier J, Pierga JY, Agostini C, Kerbrat P, Faure-Mercier C, Blanché H, Sahbatou M, Boland A, Bacq D, Besse C, Calvo F, Renaud A, Deleuze JF, Pauporté I, Thomas G, Cox DG. Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort. NPJ Breast Cancer. 2017 Feb 23;3:4. doi: 10.1038/s41523-017-0005-y. PMID: 28649644. No IF.

56 Pivot X, Spano JP, Espie M, Cottu P, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Attar-Rabia H, Benkanoun C, Dima-Martinez L, Esposito N, Gligorov J. Patients’ preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study. Eur J Cancer. 2017 Sep;82:230-236. pii: S0959-8049(17)30960-7. doi: 10.1016/j.ejca.2017.05.009. PMID: 28648618. IF: 6.029. ONCOLOGY, Q1.

57 Pivot X, Verma S, Fallowfield L, Müller V, Lichinitser M, Jenkins V, Sánchez Muñoz A, Machackova Z, Osborne S, Gligorov J; PrefHer Study Group. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. Eur J Cancer. 2017 Sep 27;86:82-90. doi: 10.1016/j.ejca.2017.08.019. [Epub ahead of print]. PMID: 28963915. IF: 6.029. ONCOLOGY, Q1.

58 Poillet-Perez L, Jacquet M, Hervouet E, Gauthier T, Fraichard A, Borg C, Pallandre JR, Gonzalez BJ, Ramdani Y, Boyer-Guittaut M, Delage-Mourroux R, Despouy G. GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells. Oncotarget. 2017 Jul 27;8(34):55998-56020. doi: 10.18632/oncotarget.19639. eCollection 2017 Aug 22. PMID: 28915569. IF: 5.168, ONCOLOGY, Q1.

59 Rangan L, Galaine J, Boidot R, Hamieh M, Dosset M, Francoual J, Beziaud L, Pallandre JR, Marie Joseph EL, Asgarova A, Borg C, Saati TA, Godet Y, Latouche JB, Valmary-Degano S, Adotévi O. Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice. Oncotarget. 2017 Jul 25;8(30):48959-48971. doi: 10.18632/oncotarget.16900. PMID: 28430664. IF: 5.168, ONCOLOGY, Q1.

60 Servagi-Vernat S, Créhange G, Bonnetain F, Mertens C, Brain E, Bosset JF. Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE). BMC Cancer. 2017 Jul 13;17(1):483. doi: 10.1186/s12885-017-3465-4. PMID: 28705182. IF: 3.288. ONCOLOGY, Q2.

61 Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, Burdaeva O, Okera M, Masuda N, Kaufman PA, Koh H, Grischke EM, Frenzel M, Lin Y, Barriga S, Smith IC, Bourayou N, Llombart-Cussac A. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy. J Clin Oncol. 2017 Sep 1;35(25):2875-2884. doi: 10.1200/JCO.2017.73.7585. PMID: 28580882. IF : 24.008. ONCOLOGY, Q1.

62 Thierry AR, El Messaoudi S, Mollevi C, Raoul JL, Guimbaud R, Pezet D, Artru P, Assenat E, Borg C, Mathonnet M, De La Fouchardière C, Bouché O, Gavoille C, Fiess C, Auzemery B, Meddeb R, Lopez-Crapez E, Sanchez C, Pastor B, Ychou M. Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment. Ann Oncol. 2017 Sep 1;28(9):2149-2159. doi: 10.1093/annonc/mdx330. PMID: 28911069. IF: 11.855. ONCOLOGY, Q1.

63 Thiery-Vuillemin A, Orillard E, Mouillet G, Calcagno F, Devillard N, Bouchet S, Royer B. Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma. Cancer Chemother Pharmacol. 2017 Jun;79(6):1273-1276. doi: 10.1007/s00280-017-3320-y. PMID: 28451830. IF: 2.737. ONCOLOGY, Q3. PHARMACOLOGY & PHARMACY, Q2.

64 Van Cutsem E, De Gramont A, Henning G, Rougier P, Bonnetain F, Seufferlein T. Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report. Cancers (Basel). 2017 May 26;9(6). pii: E59. doi: 10.3390/cancers9060059. PMID: 28587143. No IF.

65 Vienot A, Beinse G, Louvet C, de Mestier L, Meurisse A, Fein F, Heyd B, Cleau D, d’Engremont C, Dupont-Gossart AC, Lakkis Z, Tournigand C, Bouché O, Rousseau B, Neuzillet C, Bonnetain F, Borg C, Vernerey D. Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma. J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx037. PMID: 28383673. IF: 12.589. ONCOLOGY, Q1.

66 Viot J, Bachour M, Meurisse A, Pivot X, Fiteni F. Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study. Breast. 2017 Aug;34:53-57. doi: 10.1016/j.breast.2017.05.005. PMID: 2850555. IF: 2.801. ONCOLOGY, Q3. OBSTRETRICS AND GYNECOLOGY, Q1.

67 Wang L, Raffoux E, Thomas X, Yakoub-Agha I, Bouhris JH, de Botton S, Michallet M, Quoc SN, Chantepie S, Deconinck E, Caillot D, Turlure P, Vigouroux S, Pigneux A, Huynh A, Malfuson JV, Loschi M, Socie G, Dombret H, de la Tour RP, Cluzeau T. Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA. Leuk Res. 2017 Mar;54:12-16. doi: 10.1016/j.leukres.2017.01.002. PMID: 28088653. IF: 2.501. ONCOLOGY, Q3. HEMATOLOGY, Q3.


1 Badri W, Miladi K, Robin S, Viennet C, Nazari QA, Agusti G, Fessi H, Elaissari A. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study. Pharm Res. 2017 May 19. doi: 10.1007/s11095-017-2166-7. PMID: 28527126. IF: 3.002. CHEMISTRY, MULTIDISCIPLINARY, Q2. PHARMACOLOGY AND PHARMACY, Q2.

2 Calvez V, Hocqueloux L, Meynard JL, Muret P, Castan B, Tardy JC, Peytavin G, Landman R. Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why? J Antimicrob Chemother. 2017 Jan;72(1):19-28. PMID: 27655858. IF: 5.071. INFECTIOUS DISEASES, Q1. PHARMACOLOGY & PHARMACY, Q1. MICROBIOLOGY, Q1.

3 Elfatoifi FZ, Chiheb S, Humbert P. [Infrapatellar hypertrichosis in adult dermatomyositis]. Ann Dermatol Venereol. 2017 Feb;144(2):161-162. doi: 10.1016/j.annder.2016.07.012. PMID: 27765415. IF: 1.472. DERMATOLOGY, Q4.

4 Elfatoifi FZ, Fanian F, Chiheb S, Humbert P. [Hailey-Hailey disease: Efficiency of combined doxycycline and vitamin PP]. Ann Dermatol Venereol. 2017 Mar;144(3):216-217. doi: 10.1016/j.annder.2016.09.031. PMID: 28011089. IF: 1.472. DERMATOLOGY, Q4.

5 Goorochurn R, Viennet C, Tissot M, Locatelli F, Granger C, Varin-Blank N, Humbert P, Le Roy C. Differential morphological and functional features of fibroblasts explanted from Solar Lentigo. Br J Dermatol. 2017 2017 Oct;177(4):e109-e111. doi: 10.1111/bjd.15386. PMID: 28211565. IF: 4.706. DERMATOLOGY, Q1.

6 Humbert P, Courderot-Masuyer C, Robin S, Oster D, Pegahi R. Exudates absorption and proteases trapping in venous leg ulcers. J Wound Care. 2017 Jun 2;26(6):346-348. doi: 10.12968/jowc.2017.26.6.346. PMID: 28598757. IF: 1.446. DEMARTOLOGY, Q3.

7 Humbert P, Fanian F, Lihoreau T, Jeudy A, Pierard GE. Bateman purpura (dermatoporosis): a localized scurvy treated by topical vitamin C – double-blind randomized placebo-controlled clinical trial. J Eur Acad Dermatol Venereol. 2017 Aug 17. doi: 10.1111/jdv.14525. [Epub ahead of print]. PMID: 28833652. No IF.

8 Humbert P, Guichard A, Bennani I, Chiheb S. [Giardia duodenalis and its involvement in skin diseases]. Ann Dermatol Venereol. 2017 Sep 28. pii: S0151-9638(17)30311-3. doi: 10.1016/j.annder.2017.08.002. [Epub ahead of print] PMID: 2896569. IF: 1.472. DERMATOLOGY, Q4.

9 Louvrier A, Euvrard E, Nicod L, Rolin G, Gindraux F, Pazart L, Houdayer C, Risold PY, Meyer F, Meyer C. Odontoblastic differentiation of dental pulp stem cells from healthy and carious teeth on an original PCL-based 3D scaffold. Int Endod J. 2017 Jan 21. doi: 10.1111/iej.12746. [Epub ahead of print]. PMID: 28109162. IF: 3.015. DENTISTRY, ORAL SURGERY AND MEDICINE, Q1.

10 Ma YF, Yuan C, Jiang WC, Wang XL, Humbert P. Reflectance confocal microscopy for the evaluation of sensitive skin. Skin Res Technol. 2017 May;23(2):227-234. doi: 10.1111/srt.12327. PMID: 27782310. IF: 1.662. DERMATOLOGY, Q3.

11 Nakyai W, Saraphanchotiwitthaya A, Viennet C, Humbert P, Viyoch J. An In Vitro Model for Fibroblast Photoaging Comparing Single and Repeated UVA Irradiations. Photochem Photobiol. 2017 Jun 9. doi: 10.1111/php.12801. PMID: 28599356. IF: 2.121. BIOCHEMISTRY AND MOLECULAR BIOLOGY, Q3. BIOPHYSICS, Q3.

12 Suttho D, Mankhetkorn S, Binda D, Pazart L, Humbert P, Rolin G. 3D modeling of keloid scars in vitro by cell and tissue engineering. Arch Dermatol Res. 2017 Jan;309(1):55-62. doi: 10.1007/s00403-016-1703-2. PMID: 27942931. IF: 2.327. DERMATOLOGY, Q2.

13 Tiraravesit N, Humbert P, Robin S, Tissot M, Viennet C, Viyoch J. Artocarpin-enriched (Artocarpus altilis) Heartwood Extract Protects Against UVB-induced Mechanical Damage in Dermal Fibroblasts. Photochem Photobiol. 2017 May 6. doi: 10.1111/php.12788. PMID: 28477344. IF: 2.121. BIOCHEMISTRY AND MOLECULAR BIOLOGY, Q3. BIOPHYSICS, Q3.

14 Wang Y, Viennet C, Robin S, Berthon JY, He L, Humbert P. Precise role of dermal fibroblasts on melanocyte pigmentation. J Dermatol Sci. 2017 Jul 1. pii: S0923-1811(17)30082-8. doi: 10.1016/j.jdermsci.2017.06.018. [Epub ahead of print]. PMID: 28711237. IF: 3.733. DERMATOLOGY, Q1.

15 Zafar N, Robin S, Viennet C, Humbert P, Valour JP, Agusti G, Fessi H, Elaissari A. Sponge like microparticles for drug delivery and cosmeto-textile use: Formulation and human skin penetration. Int J Pharm. 2017 Oct 30;532(1):623-634. doi: 10.1016/j.ijpharm.2017.08.122. PMID: 28870768.